XORTX Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:XRTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Oct 24	BuyUS$6,889	Allen Davidoff	Individual	4,300	US$1.61
16 Sep 24	BuyUS$529	Allen Davidoff	Individual	300	US$1.76
28 Aug 24	BuyUS$1,181	Allen Davidoff	Individual	1,000	US$1.18
09 Aug 24	BuyUS$3,336	Allen Davidoff	Individual	2,000	US$1.69
05 Jul 24	BuyUS$1,807	Allen Davidoff	Individual	1,000	US$1.81
08 Mar 24	BuyUS$7,091	Anthony Giovinazzo	Individual	1,525	US$4.65
15 Feb 24	BuyUS$22,208	Allen Davidoff	Individual	10,000	US$2.22
27 Dec 23	BuyUS$1,316	Anthony Giovinazzo	Individual	600	US$2.19
13 Dec 23	BuyUS$5,593	Allen Davidoff	Individual	3,000	US$1.86
13 Dec 23	BuyUS$18,912	Anthony Giovinazzo	Individual	7,500	US$2.52
01 Dec 23	BuyUS$7,265	Allen Davidoff	Individual	3,000	US$2.42

Insider Buying: XRTX insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 61.3%.

Top 12 shareholders own 9.14% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.27%	Armistice Capital LLC	169,790	US$197.3k	0%	0.01%
2.37%	Allen Davidoff	76,557	US$89.0k	5.95%	no data
0.58%	UBS Asset Management AG	18,780	US$21.8k	0%	no data
0.3%	Anthony Giovinazzo	9,625	US$11.2k	0%	no data
0.22%	Paul Van Damme	7,110	US$8.3k	0%	no data
0.22%	James Fairbairn	6,946	US$8.1k	0%	no data
0.11%	National Bank Investments Inc.	3,440	US$4.0k	0%	no data
0.036%	Osaic Wealth, Inc. , Asset Management Arm	1,153	US$1.3k	0%	no data
0.021%	RBC Dominion Securities Inc., Asset Management Arm	672	US$781.2	-45.2%	no data
0.0086%	Clearstead Advisors, LLC	277	US$321.8	0%	no data
0.0079%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	254	US$295.2	0%	no data
0.0026%	Tower Research Capital Europe Limited	84	US$97.8	0%	no data